Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dattatraya Patil

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
BJUI Compass|January 19, 2026
Computerized tomography-derived body composition metrics are associated with 24-h urine lithogenic parametersReza Lahiji, Lorenzo Storino Ramacciotti, Ernie Morton, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
European Urology Oncology|November 24, 2023
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274E Jason Abel, Viraj A Master, Philippe E Spiess, et al.
BJU International|January 21, 2017
Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortalityKathryn L Pellegrini, Martin G Sanda, Dattatraya Patil, et al.
Urology|December 13, 2025
Understanding Chronic Opioid Use Risk Associated With Penile Cancer Treatments: A National AnalysisReza Lahiji, William Luke, Luke L Son, et al.
European Urology Open Science|March 2, 2023
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free IntervalsDaniel D Shapiro, Jose A Karam, Logan Zemp, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
Cancers|December 9, 2023
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with MetastasisCarlos S Moreno, Cynthia L Winham, Mehrdad Alemozaffar, et al.
Asian Journal of Urology|December 22, 2017
Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survivalRishi R Sekar, Claire M De La Calle, Dattatraya Patil, et al.
Urology Practice|December 1, 2025
Penile Cancer Treatments and Their Psychiatric Sequelae: A National AnalysisReza Lahiji, William Luke, Elizabeth Chu, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
BJUI Compass|January 19, 2026
Computerized tomography-derived body composition metrics are associated with 24-h urine lithogenic parametersReza Lahiji, Lorenzo Storino Ramacciotti, Ernie Morton, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
European Urology Oncology|November 24, 2023
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274E Jason Abel, Viraj A Master, Philippe E Spiess, et al.
BJU International|January 21, 2017
Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortalityKathryn L Pellegrini, Martin G Sanda, Dattatraya Patil, et al.
Urology|December 13, 2025
Understanding Chronic Opioid Use Risk Associated With Penile Cancer Treatments: A National AnalysisReza Lahiji, William Luke, Luke L Son, et al.
European Urology Open Science|March 2, 2023
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free IntervalsDaniel D Shapiro, Jose A Karam, Logan Zemp, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
Cancers|December 9, 2023
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with MetastasisCarlos S Moreno, Cynthia L Winham, Mehrdad Alemozaffar, et al.
Asian Journal of Urology|December 22, 2017
Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survivalRishi R Sekar, Claire M De La Calle, Dattatraya Patil, et al.
Urology Practice|December 1, 2025
Penile Cancer Treatments and Their Psychiatric Sequelae: A National AnalysisReza Lahiji, William Luke, Elizabeth Chu, et al.
Pageof 15